Delivery Order SPE2DB22D3301-SPE2DB26FX3XF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Nucynta (tapentadol) 100 mg tablets in a quantity of 100 units, with a contract ceiling value of $1,972.30. This is a firm fixed-price delivery order with an ultimate completion date of October 23, 2025, and was not issued under a set-aside program. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nucynta (tapentadol) 100 mg tablets in a quantity of 100 units under a firm fixed-price contract. The order, issued on October 22, 2025, carries a ceiling value of $4,550.07 with an ultimate completion date of October 23, 2025. This non-competitive delivery order represents a routine pharmaceutical procurement supporting military and federal healthcare needs. The place of performance is...
- The Defense Logistics Agency awarded a $2,862.27 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Nucynta (tapentadol) 100 mg tablets in a 100-count package. This competitively awarded, non-set-aside contract will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of August 21, 2025. The delivery order represents a child contract action under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Nucynta ER (tapentadol extended-release) 100mg tablets, valued at $6,005.43. This firm fixed-price delivery order, which represents a child contract under a larger vehicle, is scheduled for completion by August 5, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award was made through open...
- The Defense Logistics Agency awarded a $8,112 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Nucynta (tapentadol) 100 mg on September 23, 2025, with completion scheduled for September 24, 2025. This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with a ceiling value of $1,225.04 and an ultimate completion date of August 6, 2025. The award represents a non-competitive action under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $3,457.97 to AmerisourceBergen Drug Corp for the supply of Nucynta (tapentadol) 100 mg tablets in quantities of 100 units. This firm fixed-price, competitively awarded delivery order was executed on October 22, 2025, with an ultimate completion date of October 23, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this pharmaceutical procurement. This delivery order is...
- The Defense Logistics Agency awarded a $1,837.56 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with a completion deadline of July 30, 2025, and represents a child contract under AmerisourceBergen's larger federal contract portfolio. The award carries no set-aside designation, indicating it was competitively awarded. Performance will occur at the vendor's...
- The Defense Logistics Agency awarded a delivery order valued at $2,848.19 to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Nucynta (tapentadol) 50 mg tablets in a quantity of 100 units. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under the company's larger indefinite delivery contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $6,084.20 to AmerisourceBergen Drug Corp for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100 units. The contract, established under a firm fixed-price delivery order structure, was competitively awarded without set-aside provisions and is scheduled for completion by August 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB26FX3XFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Nucynta (tapentadol) 100 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order valued at $12,347.38 with an ultimate completion date of October 28, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, supplying brand-name and generic medications, vaccines, and medical supplies primarily to the Defense Health Agency and military healthcare systems. The company's extensive contract portfolio with the DLA demonstrates its capability to fulfill diverse pharmaceutical requirements across multiple therapeutic domains through competitive procurement processes. This particular delivery order for Nucynta, a controlled pain management pharmaceutical, reflects the company's ongoing role in supporting federal healthcare operations across the military supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.3k | 10/27/25 |